Influx Healthtech Stock Screener | Share Price & Fundamental Analysis
INFLUX
Pharmaceuticals
Track Influx Healthtech share price live with TickJournal's free stock screener.
Analyze Influx Healthtech share price history trends and compare 52-week high low
levels.
Calculate INFLUX stock fair value using fundamental analysis and view live share price charts.
Determine Influx Healthtech share intrinsic value and compare it with current INFLUX share price.
Record your Influx Healthtech trades in TickJournal's free trading journal and track your portfolio performance.
Influx Healthtech Market Cap
₹531.53 Cr.
EPS (TTM)
₹7.36
Dividend Yield
-
Debt to Equity
0.01
Influx Healthtech 52 Week Low
-
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹70.00
Total Equity
₹36.00
Influx Healthtech Share Price History - Stock Screener Chart
Screen INFLUX historical share price movements with interactive charts. Analyze price trends and patterns.
Influx Healthtech Company Profile - Fundamental Screener
Screen Influx Healthtech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for INFLUX shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0MYZ01012
Influx Healthtech Balance Sheet Screener
Screen INFLUX balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 70 | 41 | 28 | 18 | 0 |
| Current Assets | 49 | 26 | 20 | 14 | 0 |
| Fixed Assets | 19 | 14 | 6 | 3 | 0 |
| Liabilities | |||||
| Total Liabilities | 70 | 41 | 28 | 18 | 0 |
| Current Liabilities | 0 | 0 | 0 | 1 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 36 | 23 | 12 | 5 | 0 |
| Share Capital | 18 | 0 | 0 | 0 | 0 |
| Reserves & Surplus | 18 | 23 | 12 | 5 | 0 |
Influx Healthtech Income Statement Screener - Profit & Revenue Analysis
Screen Influx Healthtech income statement and profit fundamentals.
Analyze INFLUX quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Influx Healthtech share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|
| Revenue | 0 | 105 | 100 | 76 | 59 | 0 |
| Expenses | 0 | 84 | 83 | 65 | 53 | 0 |
| EBITDA | 0 | 21 | 17 | 11 | 6 | 0 |
| Operating Profit % | 0.00% | 20.00% | 17.00% | 14.00% | 11.00% | 0.00% |
| Depreciation | 0 | 3 | 2 | 1 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 18 | 15 | 10 | 6 | 0 |
| Tax | 0 | 5 | 4 | 3 | 2 | 0 |
| Net Profit | 0 | 13 | 11 | 7 | 5 | 0 |
| EPS | 0.00 | 7.36 | 6.13 | 3.96 | 1801.90 | -1.75 |
Influx Healthtech Cash Flow Screener - Liquidity Fundamentals
Screen INFLUX cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|
| Operating Activities | 7 | 9 | 7 | 4 | 0 |
| Investing Activities | -9 | -8 | -5 | -3 | 0 |
| Financing Activities | 0 | -1 | 0 | 1 | 0 |
| Net Cash Flow | -2 | 0 | 2 | 1 | 0 |
Influx Healthtech Shareholding Pattern Screener
See Influx Healthtech shareholding pattern with promoter, FII, and DII holdings.
Check Influx Healthtech promoter holding and ownership changes for INFLUX on TickJournal.
| Item | 2025-Sept | 2025-Jun | 2025-Feb | 2024-Oct | 2024-Sept |
|---|---|---|---|---|---|
| Promoter Holding | 73.53% | 73.53% | 99.86% | 99.86% | 99.86% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.07% | 0.32% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 13.92% | 10.89% | 0.00% | 0.00% | 0.00% |
| Other Holding | 12.48% | 15.25% | 0.14% | 0.14% | 0.14% |
| Shareholder Count | 1,022 | 9 | 9 | 9 | 9 |
Influx Healthtech Share Dividend Screener - Share Yield Analysis
Check Influx Healthtech dividend history with payout and yield data.
View Influx Healthtech dividend details including ex-dates and amounts for INFLUX stock.
Influx Healthtech Stock Index Membership
See which indices include Influx Healthtech stock.
Check INFLUX index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Influx Healthtech Market Events Screener - Corporate Actions
Get Influx Healthtech corporate actions including splits, bonuses, and buybacks.
Check Influx Healthtech stock events that may affect INFLUX share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 2.92% |
Influx Healthtech Competitors Screener - Peer Comparison
Screen INFLUX competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 407,287 | 37.56 | 54,729 | 9.71% | 10,980 | 52.49 |
| Divis Laboratories | 163,754 | 66.27 | 9,712 | 18.67% | 2,191 | 48.87 |
| Torrent Pharmaceuticals | 138,018 | 64.55 | 11,539 | 6.99% | 1,911 | 59.36 |
| Cipla | 107,555 | 23.69 | 28,410 | 7.12% | 5,291 | 35.86 |
| Dr Reddys Laboratories | 105,839 | 19.26 | 33,741 | 16.73% | 5,725 | 58.24 |
| Lupin | 100,464 | 23.23 | 22,910 | 13.74% | 3,306 | 56.93 |
| Zydus Life Science | 91,034 | 18.43 | 23,511 | 18.55% | 4,615 | 51.32 |
| Mankind Pharma | 85,058 | 47.59 | 12,744 | 20.90% | 2,007 | 42.02 |
| Aurobindo Pharma | 66,537 | 19.29 | 32,346 | 9.43% | 3,484 | 45.13 |
| Alkem Laboratories | 64,595 | 29.06 | 13,458 | 3.70% | 2,216 | 36.02 |
Influx Healthtech Company Announcements - News Screener
Screen INFLUX latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.